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SUMMARY
Since the presence of Chlamydia has been shown in synovial fluid (SF) from some patients with Chlamydia reactive arthritis,
we investigated whether anti-Chlamydia antibodies present in the joint are derived from the circulation or are locally produced.
We compared titres of IgG, IgM and IgA antibodies against Chlamydia, and against a control antigen (tetanus toxoid), by an
enzyme-linked immunosorbent assay (ELISA), in paired samples of serum and SF from Chlamydia trachomatis sexually acquired
reactive arthritis (CT-SARA) patients and from patients with other forms of arthritis. The ratio of serum/SF IgA anU-Chlamydia
antibodies was significantly decreased in CT-SARA patients. It is concluded that, in our experimental conditions, we found
evidence for intra-articular production of IgA anti-Chlamydia antibodies.
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CERTAIN infections of the urogenital tract, such as
those caused by Chlamydia trachomatis, are sometimes
followed by the development of reactive arthritis [1].
The diagnosis of the triggering infection relies on
clinical symptoms, isolation of Chlamydia from the
urogenital tract and antibody determination. The
role of serological testing in the diagnosis remains
controversial because serum antibodies against
Chlamydia are frequent in the general population.
Therefore, it could be important to investigate
joint production of anti-Chlamydia antibodies in
C. trachomatis sexually acquired reactive arthritis
(CT-SARA) patients and to examine whether
measuring specific isotypes of anii-Chlamydia
antibodies in synovial fluid (SF) can improve the
diagnosis of Chlamydia reactive arthritis. The presence
of chlamydial antigens with a strongly suggestive
appearance of elementary and reticulate bodies has
been demonstrated in articular material of patients
with arthritis following chlamydial infection [2-7].
Whole organisms could be present in some cases since
the presence of chlamydial RNA and DNA was shown
in SF and in synovium [&-11]. Thus, stimulation of B
cells by Chlamydia antigens in the joints of CT-SARA
patients could be expected with consequent higher
antibody concentration in SF than in serum, depending
on the equilibrium between both compartments.
Two studies have suggested that specific antibody
production occurs in the joint. Inman et al. [12] found
that the concentration of total polymeric IgA was
higher in SF than in serum in patients with Reiter's
disease and reactive arthritis, and Hughes et al. [13]
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found higher titres of SF chlamydial IgG antibodies
in some patients with SARA and seronegative
oligoarthritis. However, no significant differences were
found by Sieper et al. [14] in the antibody levels against
CT between serum and SF samples from patients with
undifferentiated oligoarthritis and reactive arthritis.
In order to determine whether Chlamydia antibodies
present in the SF are derived from the circulation or are
locally produced, and whether their isotype concen-
trations could be helpful for reactive arthritis diagnosis,
we compared titres of IgG, IgM and IgA antibodies
against Chlamydia and against a control antigen
[tetanus toxoid (II)] by an enzyme-linked immuno-
sorbent assay (ELISA) method, in paired samples of
serum and SF from CT-SARA patients and from
patients with other forms of arthritis. Since there are
less immunoglobulins in SF than in serum [15, 16],
we calculated the results both in units/ml of serum
or SF and in units/mg of immunoglobulins of the
corresponding isotype.
The prevalence of patients and healthy blood donors
with serum &nti-Chhmydia antibodies is discussed in
the accompanying paper.
PATIENTS AND METHODS
Only points specific to this paper are mentioned, the
rest of this section is explained in the accompanying
paper.
Patients
SF samples came from our collection. They were
centrifuged (1600g for lOmin) and aliquots of the
supernatants were kept for various times at — 70°C.
Patients were divided into the following groups. 1.
CT-SARA (n = 17): three had a positive urethral/
endocervical Chlamydia antigen detection by direct
immunofluorescence (IF), 13 had a positive urethral/
© 1996 British Society for Rheumatology
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TABLE I
Chlamydia-sped&c antibodies expressed in units/mg of immunoglobulins of the same isotype [mean ± S.D. (% of patients with antibody
concentration greateT than the mean serum values of controls •+• 3 SJ>.)*]
Group Aget IgG IgM IgA
Chlamydia trachomalis sexually acquired reactive arthritis
Sexually acquired reactive arthritis
Undifferentiated seronegative mono/oligoarthritis
Rheumatoid arthritis (n =» 6)
Crystal-induced arthritis (n «> 13)
Mechanical arthropathies (n -» 9)
Controls (blood donors) (n - 100)
25 (12%)
18-58
39 (12%)
22-42
42 (46%)
16-59
59 (83%)
45-75
51 (31%)
33-83
63 (33%)
22-80
44 (37%)
22-68
Serum
SF
Serum
SF
Serum
SF
Serum
SF
Serum
SF
Serum
SF
Serum
449 ± 728
503 ±943
381 ±689
325 ± 455
227 ±343
368 ±832
83 ± 109
123 ± 140
120 ± 122
153 ± 154
177 ± 131
204 ± 189
118± 147
(24%)
(29%)
(12%)
(18%)
(12%)
(15%)
(0%)
(0%)
(0%)
(0%)
(0%)
(0%)
(2%)
3500 ± 3762
4486 ± 4285
3968 ±9111
1976 ± 1431
1675 ± 1778
1874 ±2161
1547 ± 1373
1155 ± 1083
1656 ± 1869
1824 ± 1430
2299±2114
2191 ± 2270
1139± 1094
(24%)
(41%)
(12%)
(12%)
(15%)
(15%)
(0%)
(0%)
(8%)
(8%)
(22%)
(22%)
(2%)
310 ± 196
427 ± 260
568 ±773
592 ±666
258 ±323
533 ± 885
237 ± 182
343 ±284
240 ±226
168 ± 113
218 ±180
347 ±244
98 ± 110
(35%)
(53%)
(41%)
(41%)
(23%)
(35%)
(17%)
(33%)
(15%)
(0%)
(11%)
(44%)
(1%)
•IgG anti-Chlamydia: 559, IgM: 4421, IgA: 428.
tMedian (% of female patients) range.
endocervical Chlamydia culture and had been included
in a study on reactive arthritis [17], one had a positive
urethral Chlamydia DNA amplification with the
Amplicor test of Roche Diagnostic Systems Inc.,
Branchburg; HLA-B27: eight positive, eight negative
patients, one not determined. 2. SARA («= 17): 12
had a negative urethral/endocervical Chlamydia detec-
tion, for five patients the detection was not performed;
HLA-B27: five positive, seven negative patients, five
not determined. 3. Undifferentiated rheumatoid factor-
negative mono/oligoarthritis (n = 26): HLA-B27: three
positive, 13 negative patients, 10 not determined. 4.
Rheumatoid factor-positive rheumatoid arthritis (RA)
(n = 6). 5. Crystal-induced arthritis (n = 13): gout (7),
chondrocalcinosis (6). 6. Mechanical arthropathies
(n = 9): osteoarthritis (3), post-traumatic arthropathies
(3), meniscus lesion (2), femoropatellar chondropathies
(1).
Materials
Standard human serum was purchased from
Behringwerke AG, Marburg, Germany, and TT from
Institut Se>otherapique et Vaccinal Suisse, Berne.
Measurements of IgG, IgM and IgA by ELISA
Microtitre plates were 'coated' with the F(ab')2
fragment of polyclonal goat IgG anti-human IgG or
IgM or IgA (10 /ig/ml). A commercial serum was used
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Fio. 1.—Distribution of synovial fluid aaxi-Chlamydia antibody concentrations expressed in units/mg of immunoglobulins of the same isotype.
1. Chlamydia trachomatii sexually acquired reactive arthritis (CT-SARA), n •• 17; 2. SARA (negative or not performed urethral/endocervica]
Chlamydia detection), n » 17; 3. undifferentiated seronegative mono/oligoarthritis, n — 26; 4. rheumatoid factor-positive rheumatoid arthritis,
n «• 6; 5. crystal-induced arthritis, n = 13; 6. mechanical arthropathies, n — 9.
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TABLE II
Ratios of serum/SF Chlamydia- and tetanus toxoid-specific antibody concentrations expressed in units/rug of immunoglobulins of the same
isotype (mean ± SJX)
Group
IgG
unti-Chlamydia IgG anti-TT
IgM
tnti-Chlamydia IgM anti-TT
IgA
anti-Chlamydia
IgA
anti-TT
Patients from group 1 0.96 ± 0.38 0.83 ± 0.43
n = 16: Chlamydia trachomatis sexually acquired reactive arthritis
/-test between Chlamydia and TT results ns
0.87 ±0.38 1.01 ±0.39 0.72 ± 0.25 1.05 ±0.57
ns P = 0.05
Patients from groups 5 and 6 0.96 ± 0.61 1.47 ± 1.09 0.92 ± 0.31 1.58 ± 1.29 1.26 ± 0.82 2.42 ± 3.02
n — 15: 5 chondrocalcinosis, 5 gout, 2 post-traumatic arthropathies, 2 meniscus lesion, 1 osteoarthritis
/-test between Chlamydia and TT results ns ns
as standard. The other conditions were similar to those
described in the accompanying paper.
Measurements of anti-TT antibodies by ELISA
Microtitre plates were 'coated' with TT (3300 Lf/ml,
1.41 mg of protein/ml) diluted at 2 x 10"4 and the
other conditions were similar to those described in the
accompanying paper.
Statistical analysis
Results are expressed as the mean ± S.D. Ratios of
serum to SF Chlamydia- and TT-specific antibody
concentrations, expressed in units/mg of immuno-
globulins of the same isotype, were compared using
paired Student's r-test.
RESULTS
Serum and SF Chlamydia-specific antibody concen-
trations
The results, expressed in units/mg of immuno-
globulins of the corresponding isotype, are presented in
Table I. The CT-SARA patients had the highest means
of IgG antibodies against Chlamydia in serum and
SF (but less than the mean of serum control
values + 3 s.D.) and the highest mean of IgM in
SF (greater than the mean of serum control
values + 3 s.D.). The SARA patients had the highest
mean of IgM in serum (but less than the mean of serum
control values + 3 s.D.) and the highest means of IgA
both in serum and SF (greater than the mean of serum
control values + 3 s.D.). The means of antibodies in SF
tended to be higher than in serum, in all groups tested.
The prevalence of patients with positive results for
chlamydial antibodies was highest in the group of
patients with CT-SARA both in serum and SF, except
for IgA antibodies in serum where the prevalence was
highest in the group of SARA patients.
No difference was observed between the HLA-B27-
positive and -negative patients, either for the mean
antibody concentration of the dififerent isotypes or for
the prevalence of positive values.
SF concentrations of antibodies against Chlamydia
The distributions obtained for IgG, IgM and IgA
anti-Chlamydia antibodies, expressed in units/mg
of immunoglobulins of the same isotype, in the six
diagnostic groups of patients are given in Fig. 1.
Patients with an IgG value higher than the
mean + 3 s.D. of blood donor serum values, considered
positive for Chlamydia antibodies, were observed only
in groups 1, 2 and 3 (CT-SARA, SARA and
undifferentiated ser Onega tive mono/oligoarthritis).
Patients with IgM and IgA values higher than the
mean + 3 s.D. of blood donor serum values were
observed in all groups tested, except group 4 (RA) for
IgM and group 5 (crystal-induced arthritis) for IgA.
Ratios of serum to SF Chlamydia- and TT-specific
antibody concentrations expressed in units/mg of
immunoglobulins of the same isotype
These ratios were only determined for patient groups
1, 5 and 6 when sufficient material was still available.
The results obtained for CT-SARA patients (group 1)
compared to those obtained for crystal-induced
arthritis and mechanical arthropathies (group 5 and 6)
are presented in Table II.
The means of the ratios were not significantly
different when we compared results obtained for the
same patients with Chlamydia or TT as antigen, except
for IgA of CT-SARA patients where the ratio
calculated for the Chlamydia antigen was lower than
that calculated for TT.
DISCUSSION
From the present study, we observed that the groups
of patients with CT-SARA and SARA had the highest
means of serum and SF antibodies against Chlamydia.
The existence of an intra-articular specific B-cell
response in CT-SARA patients and its possible
diagnostic importance could be documented by
comparing the chlamydial antibody concentrations
in both serum and SF. The ratios of serum to SF
chlamydial antibody concentrations expressed in
units/ml of sample were always higher than one (the
value representing antibody concentration equality
between serum and SF) (data not shown). However, it
is known that the Ig concentration is lower in SF than
in serum: in normal joint fluid, the IgG concentration
is ~ 25-30% of the serum IgG concentration [15, 16],
indicating that some degree of a blood-joint barrier
exists. In the RA inflammatory joint, permeability
increases over 40 times for macroglobulins [18].
Consequently, as the degree of joint inflammation
varies between the different patients, an appropriate
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comparison between both compartments has to be
made by expressing the results in units/mg of
immunoglobulins of the same isotype, present in the
same sample. When our results are expressed in
units/mg of the corresponding immunoglobulins,
chlamydial antibody concentrations tended to be
higher in SF than in serum, in all groups tested. The
increase in antibody concentrations in SF could be
explained by local antibody production. If intra-
articular stimulation by antigen could be possible for
patients with CT-SARA, SARA or undifferentiated
seronegative mono/oligoarthritis, it is unlikely for the
other patients and could be due to non-specific
phenomena, such as the extensive transudation of
proteins through the inflamed synovial membrane.
Indeed, activation of B cells could occur inside the
joint or outside with subsequent transudation of
antibody into the joint fluid, or vice versa. In order
to differentiate between transudation and local
production, we examined the B-cell response directed
to TT, a common antigen, without a known link to
arthritis and assumed to be not compartmentalized to
the joint. In all groups of patients studied, samples with
Chlamydia and TT antibody level higher in SF than
in serum were found, which is likely to be due to
antigen-independent reactions. During inflammation,
B cells could be present in the joint due to non-specific
recruitment. It is possible that upregulation of adhesion
molecules on the surfaces of endothelial cells and B
cells is sufficient to increase their entry into the joint
without regard to antigen specificity. Non-specific
recruitment of the memory cells can also occur [19]. A
general stimulation of B cells locally present due to
different factors of inflammation or to more efficient
T-cell help or to differences in the antigen-presenting
cell population within the joint as compared to
peripheral blood might be involved [20]. However, for
IgA of the CT-SARA patients, the mean of the ratios
of serum to SF antibody concentrations calculated for
the Chlamydia antigen was significantly lower than that
calculated for TT. From our results, an intra-articular
IgA production in response to local microbial antigen
is therefore likely. Our results agree with those of
Inman et al. [21] who observed an increase in
Chlamydia-STpeci&c IgA in the SF during the disease
process in a patient with Reiter's syndrome. This
observation is in line with a report of intra-articular
production of Salmonella antibodies of the IgA2
subclass [22]. Whether intra-articular stimulation exists
only for this isotype is unknown. Even if the differences
between CT and TT are not significant for IgG and
IgM antibodies, the SF may have contained locally
produced antibodies and some of these SF antibodies
could have been bound to local Chlamydia antigens
and remained undetectable.
To explain the higher amount of antibodies in the
SF, two mechanisms could co-exist: an antigen-driven
stimulation only detectable with IgA in our study and
non-specific phenomena. In order to know whether
IgG or IgM Chlamydia antibodies present in the SF are
derived from the circulation or are locally produced,
other investigations could be carried out, such as the
use of other antigens with Chlamydia epitopes more
closely involved in reactive arthritis, the comparative
analysis of antibody specificities in both compartments
or the demonstration of a relative accumulation of
antibody-secreting cells in joint fluid.
To summarize, in our experimental conditions, the
measurement of specific isotypes of &nti-Chlamydia
antibodies in SF cannot improve the diagnosis of
Chlamydia reactive arthritis. However, an intra-
articular production of IgA unti-Chlamydia antibodies
was observed.
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